The PANACEA Breast Cancer Clinical Trial - Breast Cancer Trials
The PANACEA clinical trial aims to find out the most suitable dose of MK-3475 and trastuzumab when these drugs are used together and to assess if their combined use is an effective treatment. This is the first trial to test the combination of the two drugs and it is hoped that it will provide evidence of a new treatment option for women diagnosed with advanced breast cancer that is HER2-positive.
